Sugi Predict

Sugi Predict / Compounds / SCHEMBL4131729

SCHEMBL4131729

SCHEMBL4131729

O=C1COc2ccc(-c3ccc4cc(-c5nc6cc(C(=O)O)ccc6n5C5CCCCC5)ccc4n3)cc2N1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ GAA P10253 3/20 0.41
▸ PIK3CA P42336 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ CPT2 P23786 2/20 0.39
▸ CPT1A P50416 2/20 0.39
▸ CPT1B Q92523 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMYD3 Q9H7B4 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PKM P14618 1/20 0.37
▸ PADI4 Q9UM07 2/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ IDH1 O75874 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4130618 0.85 L3MBTL1 (0.52) L3MBTL1GAAKDM4ERAB9ANPC1
SCHEMBL4125474 0.83 L3MBTL1 (0.49) L3MBTL1GAAKDM4EALDH1A1HSD17B10
SCHEMBL4125294 0.82 L3MBTL1 (0.58) L3MBTL1GAAHSD17B10IDH1
SCHEMBL4130835 0.81 L3MBTL1 (0.58) L3MBTL1GAAHSD17B10IDH1
SCHEMBL4122761 0.81 L3MBTL1 (0.57) L3MBTL1GAAHSD17B10IDH1
SCHEMBL4125845 0.81 L3MBTL1 (0.54) L3MBTL1GAAHPGDHSD17B10IDH1
SCHEMBL4117901 0.80 L3MBTL1 (0.56) L3MBTL1GAAHSD17B10IDH1
SCHEMBL4130712 0.80 L3MBTL1 (0.56) L3MBTL1GAAKDM4EALDH1A1MAPT
SCHEMBL4125565 0.80 L3MBTL1 (0.56) L3MBTL1GAAHPGDHSD17B10IDH1
SCHEMBL4140579 0.80 L3MBTL1 (0.53) L3MBTL1GAAHSD17B10IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187390-A1 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. 2005-08-25 — — US claimed
US-7511145-B2 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. (US) 2009-03-31 — — US disclosed
US-7511145-B2 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. (US) 2009-03-31 — — US disclosed
US-7511145-B2 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. (US) 2009-03-31 — — US disclosed
US-20090081165-A1 BICYCLIC HETEROARYL DERIVATIVES GENELABS TECHNOLOGIES, INC. 2009-03-26 — — US disclosed
US-20090081165-A1 BICYCLIC HETEROARYL DERIVATIVES GENELABS TECHNOLOGIES, INC. 2009-03-26 — — US disclosed
US-20090081165-A1 BICYCLIC HETEROARYL DERIVATIVES GENELABS TECHNOLOGIES, INC. 2009-03-26 — — US disclosed
US-20050187390-A1 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. 2005-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090081165-A1 BICYCLIC HETEROARYL DERIVATIVES HAVCR2, MAVS, ZC3HAV1 L3MBTL1 1221/4885GAA 1157/4885PIK3CA 1303/4885
US-20050187390-A1 Bicyclic heteroaryl derivatives HAVCR2, MAVS, ZC3HAV1 L3MBTL1 1221/4885GAA 1157/4885PIK3CA 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.